Skip to main content
Year archive

RACURA ONCOLOGY LTD — 2020 filings

All 117 regulatory filings released by RACURA ONCOLOGY LTD (RAC) in 2020, sourced directly from the official regulator.

117 Filings
2020 Period
2020 filings (117)
Filing Released Lang
Appendix 2A 15 pages 174.1KB
Share Issue/Capital Change
2020-12-21 English
Cleansing Notice 1 page 97.4KB
Share Issue/Capital Change
2020-12-21 English
Race receives $387k R&D tax incentive refund 1 page
Capital/Financing Update
2020-12-16 English
Race releases 2020 AGM presentation video 2 pages 96.2KB
AGM Information
2020-12-15 English
Prof Andersson resigns from Board to focus on CMO role 2 pages 104.8KB
Board/Management Information
2020-12-09 English
Final Director's Interest Notice 2 pages 145.1KB
Director's Dealing
2020-12-09 English
Appendix 2A 15 pages 173.9KB
Share Issue/Capital Change
2020-12-09 English
Cleansing Notice 1 page 96.9KB
Share Issue/Capital Change
2020-12-09 English
Change in substantial holding 2 pages 193.2KB
Regulatory Filings
2020-11-30 English
Race AGM presentations and strategic update 33 pages 7.5MB
AGM Information
2020-11-29 English
Results of Meeting 3 pages 83.6KB
Declaration of Voting Results & Voting Rights Announcements
2020-11-29 English
Replacement Constitution 72 pages 545.6KB
Governance Information
2020-11-29 English
Appendix 3Gs 13 pages 143.8KB
Share Issue/Capital Change
2020-11-29 English
Appendix 3Y-Phillip Lynch 2 pages 89.5KB
Director's Dealing
2020-11-29 English
Appendix 3Y-Daniel Tillett 2 pages 83.5KB
Director's Dealing
2020-11-29 English
Appendix 3Y-Prof Borje Andersson 2 pages 84.6KB
Director's Dealing
2020-11-29 English
Breast Cancer Clinical Trial Program Initiated 2 pages 170.7KB
Regulatory Filings
2020-11-25 English
Impressive Preclinical Bisantrene Breast Cancer Results 7 pages 1.3MB
Regulatory Filings
2020-11-23 English
Appendix 2A-Exercise of Options 15 pages 175.1KB
Capital/Financing Update
2020-11-15 English
Cleansing Notice 1 page 106.3KB
Capital/Financing Update
2020-11-15 English
Bisantrene data published in European Journal of Haematology 2 pages 168.8KB
Regulatory Filings
2020-11-09 English
Phase II Bisantrene trial data to be presented at ASH 2020 1
Regulatory Filings
2020-11-04 English
Annual Report to Shareholders 67 pages 1.6MB
Annual Report FY 2020
2020-10-28 English
Quarterly Activity Report & Appendix 4C 8 pages 185.9KB
Interim / Quarterly Report Q1 2021
2020-10-28 English
Director Resignations 1 page 98.9KB
Board/Management Information
2020-10-27 English
Appendix 3Z- Bill Garner 2 pages 177.6KB
Director's Dealing
2020-10-27 English
Appendix 3Z-Chris Ntoumenopoulos 2 pages 178.0KB
Director's Dealing
2020-10-27 English
Letter to Shareholders, Notice of AGM & Proxy Form 48 pages 1.1MB
AGM Information
2020-10-27 English
Date of AGM & Closing Date for Director Nominations 1
AGM Information
2020-10-08 English
Prof Borje S Andersson appointed Chief Medical Officer 3 pages 119.5KB
Board/Management Information
2020-10-01 English
Race appoints clinical & FDA regulatory strategy advisor 2 pages 109.8KB
Regulatory Filings
2020-09-17 English
Appendix 2A 15 pages 173.4KB
Regulatory Filings
2020-09-02 English
Cleansing Notice 1 page 106.5KB
Share Issue/Capital Change
2020-09-02 English
Race leadership team strengthened 4 pages 126.6KB
Board/Management Information
2020-09-01 English
Final share buy-back notice - Appendix 3F 2 pages 295.1KB
Transaction in Own Shares
2020-08-26 English
ASIC Form 484 - Cancellation of Shares 2 pages 127.6KB
Share Issue/Capital Change
2020-08-26 English
Change of Registered Office 1 page 101.2KB
Regulatory Filings
2020-08-26 English
Apppendix 3Y - Bill Garner 3 pages 221.2KB
Director's Dealing
2020-08-26 English
Appendix 4E & Annual Report 69 pages 1.6MB
Annual Report FY 2020
2020-08-26 English
Appendix 4G 9 pages 364.8KB
Regulatory Filings
2020-08-26 English
Appendix 2A 15 pages 174.8KB
Share Issue/Capital Change
2020-08-20 English
Cleansing Notice 1 page 106.2KB
Capital/Financing Update
2020-08-20 English
Change in substantial holding 2 pages 145.3KB
Regulatory Filings
2020-08-13 English
Strategic investors make further $1.5m investment in Race 1
Capital/Financing Update
2020-08-11 English
Appendix 2A 15 pages 173.3KB
Share Issue/Capital Change
2020-08-11 English
Cleansing Notice 1 page 106.3KB
Share Issue/Capital Change
2020-08-11 English
Results of Meeting 2 pages 120.8KB
Declaration of Voting Results & Voting Rights Announcements
2020-08-10 English
Appendix 3C 3 pages 201.2KB
Transaction in Own Shares
2020-08-09 English
Quarterly Activity Report & Appendix 4C 8 pages 202.7KB
Interim / Quarterly Report Q4 2020
2020-07-28 English
Trading Policy 8 pages 62.1KB
Governance Information
2020-07-23 English
Race secures fourth US patent for bisantrene 1 page
Regulatory Filings
2020-07-21 English
Race to present at IRD Invest virtual, investor conference 1
Investor Presentation
2020-07-21 English
Appendix 2A 15 pages 173.2KB
Capital/Financing Update
2020-07-15 English
Cleansing Notice 1 page 106.3KB
Capital/Financing Update
2020-07-15 English
Investor Update 31 pages 3.2MB
Investor Presentation
2020-07-14 English
Change in substantial holding 2 pages 149.4KB
Major Shareholding Notification
2020-07-14 English
Appendix 2A 15 pages 173.9KB
Regulatory Filings
2020-07-13 English
Cleansing Notice 1 page 105.9KB
Share Issue/Capital Change
2020-07-13 English
Change in substantial holding 2 pages 49.6KB
Major Shareholding Notification
2020-07-13 English
A$3m strategic investment from prominent biotech investors 2 pages 117.9KB
Capital/Financing Update
2020-07-12 English
Proposed issue of Securities - RAC 5 pages 27.7KB
Capital/Financing Update
2020-07-12 English
Notice of General Meeting/Proxy Form 57 pages 1.4MB
Regulatory Filings
2020-07-09 English
Letter to Shareholders-Upcoming General Meeting 2 pages 289.7KB
AGM Information
2020-07-09 English
Trading Halt 2 pages 523.5KB
Capital/Financing Update
2020-07-08 English
Appendix 2A 15 pages 173.3KB
Regulatory Filings
2020-07-05 English
Cleansing Notice 1 page 106.2KB
Share Issue/Capital Change
2020-07-05 English
Appendix 2A 15 pages 173.3KB
Share Issue/Capital Change
2020-06-30 English
Cleansing Notice 1 page 106.3KB
Share Issue/Capital Change
2020-06-30 English
Cancer Cell Journal Publication 1 page 100.0KB
Regulatory Filings
2020-06-28 English
Appendix 3Y-Phillip Lynch 2 pages 83.0KB
Director's Dealing
2020-06-28 English
Appendix 2A 15 pages 175.0KB
Share Issue/Capital Change
2020-06-21 English
Cleansing Notice 1 page 106.3KB
Share Issue/Capital Change
2020-06-21 English
Notification of Lapse of Unlisted Options 1 page 97
Share Issue/Capital Change
2020-06-18 English
Webinar transcript and presentation update 17 pages 293.0KB
Call Transcript
2020-06-18 English
Updated Bisantrene Phase II Data Presentation 23 pages 3.1MB
Investor Presentation
2020-06-18 English
Race Oncology Phase II Bisantrene AML trial webinar 24 pages 3.1MB
Investor Presentation
2020-06-16 English
Impressive 40% response in Phase II Bisantrene AML Trial 8 pages 220.1KB
Capital/Financing Update
2020-06-15 English
Extension of time to repay loan through share buy-back 2 pages 98.3KB
Capital/Financing Update
2020-06-15 English
Trading Halt 2 pages 509.0KB
Regulatory Filings
2020-06-11 English
Phillip Lynch appointed Director of Race 2 pages 105.5KB
Board/Management Information
2020-05-31 English
Initial Director's Interest Notice 2 pages 66.2KB
Director's Dealing
2020-05-31 English
Extension of time to repay loan 1 page 97.1KB
Capital/Financing Update
2020-05-27 English
Final Director's Interest Notice 2 pages 28.4KB
Director's Dealing
2020-05-20 English
Managing Director Resignation 2 pages 125.3KB
Board/Management Information
2020-05-19 English
Pause in Trading 1 page 111.9KB
Regulatory Filings
2020-05-17 English
Trading Halt 2 pages 180.7KB
Regulatory Filings
2020-05-17 English
Race starts preclinical breast cancer study for Bisantrene 2 pages 137.2KB
Regulatory Filings
2020-05-13 English
Quarterly Activity Report & Appendix 4C 8 pages 171.2KB
Interim / Quarterly Report Q3 2020
2020-04-21 English
Notification of Lapse of Unlisted Options 1 page 10
Share Issue/Capital Change
2020-03-22 English
Notification of Expiry of Unlisted Options 1 page 1
Capital/Financing Update
2020-03-19 English
Phase II Bisantrene Trial Recruitment Completed 1 p
Regulatory Filings
2020-03-17 English
Appendix 2A 15 pages 173.6KB
Share Issue/Capital Change
2020-03-12 English
Cleansing Notice 1 page 104.5KB
Share Issue/Capital Change
2020-03-12 English
Appendix 2A-Completion of Placement 15 pages 188.0KB
Capital/Financing Update
2020-03-11 English
Cleansing Notice 1 page 102.6KB
Share Issue/Capital Change
2020-03-11 English
Appendix 3Y-William Garner 3 pages 149.6KB
Director's Dealing
2020-03-10 English
Change in substantial holding 2 pages 93.9KB
Major Shareholding Notification
2020-03-10 English
Becoming a substantial holder 2 pages 192.9KB
Regulatory Filings
2020-03-10 English
Race further strengthens Clinical Advisory Board 2 pages 114.3KB
Board/Management Information
2020-03-09 English
Race Secures A$1.8m strategic placement 2 pages 112.5KB
Capital/Financing Update
2020-03-05 English
Proposed issue of Securities - RAC 6 pages 31.5KB
Capital/Financing Update
2020-03-05 English
Dr John Cullity appointed Non-Executive Chairman 2 pages 107.4KB
Board/Management Information
2020-03-05 English
Trading Halt 2 pages 691.5KB
Capital/Financing Update
2020-03-03 English
Appendix 3Y-Dr Daniel Tillett 2 pages 81.0KB
Director's Dealing
2020-03-01 English
Appendix 2A 15 pages 173.2KB
Regulatory Filings
2020-02-26 English
Cleansing Notice 1 page 140.2KB
Share Issue/Capital Change
2020-02-26 English
Appendix 4D & Half-Year Financial Statements 24 pages 947.9KB
Interim / Quarterly Report H1 2020
2020-02-24 English
Race significantly strengthens Clinical Advisory Board 2 pages 116.7KB
Board/Management Information
2020-02-19 English
Race appoints Australian Clinical Program Director 2 pages 104.2KB
Board/Management Information
2020-02-16 English
Appendix 3G 15 pages 212.8KB
Share Issue/Capital Change
2020-02-16 English
Appendix 3X-Prof Borje Andersson 2 pages 71.3KB
Director's Dealing
2020-02-02 English
December 2019 Quarterly Report 7 pages 272.3KB
Interim / Quarterly Report Q2 2020
2020-01-29 English
Prof Borje Andersson appointed as Non-Executive Director 2 pages 108.8KB
Board/Management Information
2020-01-27 English
Clarification Announcement 1 page 95.4KB
Board/Management Information
2020-01-27 English
Appendix 3B 10 pages 105.5KB
Capital/Financing Update
2020-01-27 English
Notification of Expiry of Unlisted Options 1 page 1
Capital/Financing Update
2020-01-13 English
Australian Clinical Trials Manager to replace European Role 1
Board/Management Information
2020-01-12 English